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ORIGINAL ARTICLE
Quantitative ultrasound shear wave 
elastography (USWE)-measured tissue 
stiffness correlates with PIRADS scoring 
of MRI and Gleason score on whole-mount 
histopathology of prostate cancer: implications 
for ultrasound image-guided targeting 
approach
Wael Ageeli1,6, Cheng Wei1, Xinyu Zhang2, Magdalena Szewcyk‑Bieda3, Jennifer Wilson4, Chunhui Li5 and 
Ghulam Nabi1* 
Abstract 
Objective: To correlate quantitative tissue stiffness measurements obtained by transrectal ultrasound shear wave 
elastography (USWE) with PI‑RADS scoring of multiparametric magnetic imaging resonance (mpMRI) using Gleason 
scores of radical prostatectomy as a reference standard.
Patients and methods: 196 men with localised prostate cancer were prospectively recruited into the study and had 
quantitative prostate tissue stiffness measurements in kilopascals (kPa) using transrectal USWE prior to radical prosta‑
tectomy. PI‑RADS scores of mpMRI were also obtained in all the men. Imaging and histopathology of radical prosta‑
tectomy specimen were oriented to each other using patient specific customised 3D moulds to guide histopathology 
grossing of radical prostatectomy specimens. All included patients had confirmed PCa on TRUS‑guided biopsies, had 
both USWE and mpMRI imaging data, and underwent radical prostatectomy. Chi‑square test with 95% confidence 
interval was used to assess the difference between Gleason score (GS) of radical prostatectomy and PI‑RADS clas‑
sification, as well as GS of radical prostatectomy and stiffness (in Kpa) using USWE. The correlation coefficient (r) was 
calculated in order to investigate relation between PI‑RADS classification and tissue stiffness in kPa.
Results: There was a statistically significant correlation between USWE‑measured tissue stiffness and GS (χ2 (2, 
N = 196) = 23.577, p < 0.001). Also, there was a statistically significant correlation between Gleason score and PI‑RADS 
score (χ2 (2, N = 196) = 12.838, p = 0.002). High PIRADS on MRI and high stiffness on USWE (> 100 kPa) detected more 
than 80% and 90% high risk prostate cancer disease. However, a weak correlation coefficient of 0.231 was observed 
between PI‑RADS score and level of tissue stiffness measured in kPa.
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original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
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Key points
• The study confirms a strong correlation between 
PIRADS score on MRI and tissue stiffness measured 
by ultrasound shear wave elastography and Gleason 
score of histology in prostate cancer.
• The study used imaging-derived 3D printed moulds 
to orient histopathology section to pre-surgical imag-
ing.
• Findings from this study have implications for image 
guided biopsies and image fusion technology for the 
detection of prostate cancer.
Introduction
Prostate cancer (PCa) is one of the most common can-
cers responsible for mortality in men [1]. Screening of 
asymptomatic men for PCa is carried out using serum 
prostate-specific antigen (PSA) combined with digital 
rectal examination (DRE). The specificity of serum PSA 
test and DRE remains low [2–4]. Therefore, confirma-
tion of diagnosis requires further microscopic examina-
tion of tissue obtained using transrectal or transperineal 
ultrasound-guided biopsies. Histopathology of prostate 
biopsy is necessary to confirm diagnosis.
There is an increased awareness that traditional tran-
srectal ultrasound-guided systemic biopsy approach 
based on random sampling misses csPCa. This is due 
to limitations of B-mode greyscale ultrasound imaging 
which has a high false-negative rate [5, 6]. To mitigate this 
and improve sampling of prostate gland, increased num-
ber of systematic biopsies have been suggested which can 
result in associated increased risk of complications [7, 
8]. Therefore, imaging facilitated sampling of abnormal 
areas is an emerging strategy to achieve a balance.
Multiparametric magnetic resonance imaging 
(mpMRI) and transrectal ultrasound (TRUS) are the pri-
mary imaging modalities for characterising PCa prior to 
biopsy. A grey-scale transrectal ultrasound (TRUS) is a 
low cost, but has limited sensitivity and specificity (40–
50%) in the detection or characterisation of PCa [9, 10]. 
mpMRI has been promising in characterising abnormal 
areas using PI-RADS score, and studies have reported 
that MRI-TRUS fusion-guided targeted biopsy of the 
prostate has a higher detection rate of csPCa compared 
to systematic biopsy [11, 12]. On contrary, other stud-
ies were unable to demonstrate this superiority of MRI-
TRUS fusion-guided targeted biopsy in the detection of 
PCa compared to systematic biopsy [13, 14]. mpMRI has 
limitations such as contraindications (Pacemaker, claus-
trophobia, etc.), scan time, and high cost [15].
We and others have recently reported on quantitative 
transrectal ultrasound shear wave elastography in the 
detection and characterisation of prostate cancer [16–
18]. USWE-measured tissue stiffness can be a good bio-
physical marker of prostate Gleason score [16]; however, 
we do not know, how this will compare to mpMRI-based 
PI-RADS scoring. If further research validates good cor-
relation then USWE-detected lesions could be targeted 
as an alternate technique to MRI-TRUS fusion-guided 
method. Moreover, stiffer tissues provide a unique micro-
environment to cancer cells and promote metastases [17] 
and quantitative measurement may help in stratifying 
men to different therapeutic options. It is well known 
that cells respond and change their biophysical charac-
teristics in response to cues from the extracellular matrix 
[17]. Whether measurement and quantification of tissue 
stiffness using ultrasound can provide some insight into 
tumour behaviour in prostate cancer has been scantly 
reported [18].
Quantitative image analysis for size, texture, and 
number of tumours is used clinically to assess tumour 
response to therapeutic interventions [19]. However, 
reproducible, easy to interpret, and quantifiable imaging 
modality in prostate cancer detection is still not clinically 
available. USWE with pseudo-colour-coded quantifiable 
images into red and blue provides an easy estimate of tis-
sue stiffness (Fig. 2b). The aim of the present study was to 
find out the correlation between USWE-measured stiff-
ness and PI-RADS scores using mpMRI in detecting risk-
stratified Gleason scores of prostate cancer.
Patients and methods
Study design and patients
The study assessed images retrospectively obtained as 
part of protocol-driven study with prior ethical approval 
through East of Scotland Ethical committee and Cal-
dicott permission (IGTCAL5626) to access the health-
care follow-up data [16]. Table 1 shows detailed patient 
and imaging characteristics.
Inclusion criteria were:
Conclusion: Quantitative USWE and mpMRI using PI‑RADS classification provide a good degree of prediction for 
Gleason score of clinically significant prostate cancer (csPCa). Stiffer lesions on ultrasound showed a weak correlation 
with PI‑RADS scoring system. USWE could be used to target suspected prostate cancer.
Keywords: Prostate, Ultrasonography, Magnetic resonance imaging, Shear wave elastography
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1) Patients with confirmed PCa on TRUS-guided biop-
sies, coupled with both availability of both pre-surgi-
cal USWE and mpMRI, and
2) The diagnosis confirmed by radical prostatectomy as 
a gold standard.
Patients were excluded if whole amount pathology 
images, USWE images, mpMRI images were unavail-
able (n = 16) or patients with prior radiotherapy, trans-
urethral resection of prostate and hormonal therapy. a 
total of 196 patients, met the inclusion criteria (Fig. 1).
The primary outcome of the study was the degree of 
correlation between USWE-measured tissue stiffness 
and PI-RADS scores of mpMRI using histopathology of 
radical prostatectomy as a reference standard. The sec-
ondary outcome was the correlation between PI-RADS 
score and GS of histopathology.
Multiparametric magnetic resonance imaging
MRI imaging was conducted for each patient 6–8 weeks 
after biopsy confirmed prostate cancer with a 3-T 
scanner (TIM Trio, Siemens, Erlangen, Germany) to 
avoid blood atrifacts caused by biopsy. MRI protocol 
for prostate cancer was acquired from the 2012 Euro-
pean Society of Uro-radiology Guidelines (ESUR)[20]. 
T1-weighted imaging (T1WI), T2-weighted imaging 
(T2WI), diffusion-weighted imaging (DWI); appar-
ent diffusion coefficient (ADC), and dynamic contrast 
enhancement (DCE) were carried out with a transab-
dominal external phased array coil. Table 2 summarises 
the MRI acquisition protocol. All MRI images were 
analysed by two experienced uro-radiologists (SMB, SJ) 
working in consensus and blinded to clinicopathologi-
cal features. The lesions seen on mpMRI were classified 
using PI-RADS v2 scoring system.




 Mean ± SD 66 ± 5
 Median (IQR) 66.5 (63–72)
PSA level (ng/ml)
 Mean ± SD 12 ± 7.8
 Median (IQR) 9.8 (7.5–13.1)
Prostate weight
 Mean ± SD 66 ± 29.7
 Median (IQR) 59 (46.5–76)
PSA density (ng/ml2)
 Mean ± SD 0 ± 0.2
 Median (IQR) 0.2 (0.1–0.2)
Stiffness measurement using USWE in Kilopascals (mean ± SD) No. (%)
≤ 100 (94 ± 10.3) 43 (21.9)
100–130 (115 ± 11.4) 47 (24)
> 130 (138.4 ± 29) 106 (54.1)
Gleason score No. (%)
3 + 3 3 (1.5)
3 + 4 94 (48)
4 + 3 33 (16.8)
3 + 5 18 (9.2)
4 + 4 3 (1.5)
4 + 5 or greater 45 (23)
PI-RADS categories No. (%)
PIRADS 3 16 (8.16)
PIRADS 4 45 (22.96)
PIRADS 5 135 (68.88)
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Ultrasound shear wave elastography
The USWE technique has been described in detail 
in previous publications [21, 22]. All USWE images 
were obtained using a transrectal endocavitory trans-
ducer (SuperSonic  Imagine,  Aix  en  Provence,  France) 
with patients either in lateral or lithotomy position. 
USWE mode was applied and elastograms of the pros-
tate were acquired from cranial to caudal direction for 
each prostate lobe (Fig.  2). USWE examinations were 
performed by an experienced urologist with more than 
10  years of experience in transrectal ultrasound. The 
USWE images were taken from base to apex in trans-
verse planes with a gap of 4–6 mm. The most suspect 
planes containing cancer were labelled and rebuilt 
offline into 3D images. Rotating transducer in different 
directions to scan suspicious cancer regions ensured 
verification of abnormalities and accurate measure-




Inclusion and exclusion criteria
Fig. 1 Flowchart shows inclusion and exclusion criteria and the patients selection process
Table 2 MRI acquisition parameters
T1WI High resolution T2WI DWI DCE
Axial Sagittal Axial Coronal DWI DWI high b-value Dyn Gd-MRI
TR (ms) 650 6000 4000 5000 3300 3300 4.76
Sequence 2DTSE 2DTSE 2DTSE 2DTSE 2DEPI 2DEPI 3D VIBE
TE (ms) 11 102 100 100 95 95 2.45
Flip angle (°) 150 140 150 150 – – 10
Slice thickness (mm) 3 3 3 3 3 3 3
Slice gap (mm) 0.6 0.6 0.6 0.6 0 0 0.6
Resolution (pixels) 320 320 320 320 192 192 192
FOV (mm) 200 200 200 200 280 280 280
b‑values (s/mm2) – – – – 50, 100, 500, 1000 2000 –
Temporal resolution (s) – – – – – – –
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and normal areas and three stiffness measurements of 
shear wave speed in m/s or Young’s modulus in kPa 
using pseudo-colour map with a 82.6  kPa as a cutoff 
value for benign vs. malignant tissue from previous 
published paper was recorded by three researchers 
(G.N., C.W. and D.U.) independently [23]. Based on 
data from same study, we categorised tissue stiffness 
into < 100 kPa; 100–130 kPa; and > 130 kPa.
Radical prostatectomy histopathology as reference 
standard
Patient-specific customised 3D moulds were built 
using imaging and 3-D printed according to our pub-
lished protocol for each included men in the study 
[24]. The patient-specific customised 3D moulds were 
printed before surgery based on the T2-weighted 
mpMRI prostate images. They were built to keep pros-
tates after surgical removal in the same form and ori-
entation as seen on MRI. The 3D mould contains a 
series of evenly spaced parallel slits, each correspond-
ing to a recognised slice of T2-weighted MRI (Fig. 3). 
This allows pathologist to gross specimen in the same 
orientation as imaging. The prostate specimens were 
immediately cut from base to apex in the axial orienta-
tion using a multi-bladed cutting tool [24].
Data analysis
In all patients, pathological GS was determined by an 
experienced uro-pathologist (J.W.). Chi-square test 
was conducted to evaluate the difference between GS 
of radical prostatectomy and PI-RADS classification, as 
well as GS of radical prostatectomy and tissue stiffness 
(in kPa) using USWE. Pearson Chi-square value, degree 
of freedom, p value and 95% confidence intervals were 
calculated and presented. The degrees of freedom (df ) 
for the Chi-square were calculated using the following 
formula: df = (r − 1)*(c −1) where r was the number of 
rows and c was the number of columns. The confidence 
interval (CI) calculated the lower and upper limits of 
the 95% confidence interval for the difference between 
two independent proportions, according to the method 
described by Robert Newcombe [25], derived from a 
procedure outlined by Wilson [26]. The CI calcula-
tion used the Wilson procedure with a correction for 
continuity.
In order to investigate the correlation between two cat-
egorical variables, Chi-square test of independence was 
applied on PI-RADS classification and stiffness data. 
Then the correlation coefficient (r) was calculated by 
the formula below, where χ2 was the Pearson Chi-square 
value and n equalled to the total number of patients with 
prostate cancer:
Fig. 2 a Histopathology of whole‑mount prostate with Gleason score 4 + 5 cancer in dotted area. b Ultrasound shear wave elastography USWE 
with pseudo‑colour map; note cursor in red area with bar showing a quantitative stiffness measurement of 145.5 kPa (very high grade). B‑Mode 
ultrasound showing no clue of suspected cancer. c, d T2w and ADC map images of the lesion from 3 T mpMRI scored as PI‑RADS 5
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The correlation coefficient greater than 0.5 suggested 
a moderate positive relationship between the two 
variables and the correlation coefficient in the range 
0.7 ≤ r ≤ 1.0 represents a strong positive association.
In this study, Gleason scores 3 + 3 and 3 + 4 were con-
sidered as low/intermediate risk prostate cancer (group 
1); Gleason score ≥ 4 + 3 was considered to be high-risk 
prostate cancer following University College London 
(UCL) 1 definition, (group 2) [27]. The data included 
in this study are available to third party through proper 
request as per institutional guidelines.
Results
A total of 196 patients of clinically localised PCa with a 
mean age of 66 years (range 53–77 years), and mean PSA 
level of 11.7 ng/ml (range 0.1–47.7 ng/ml) were enrolled 
into the study. All patients had extraperitoneal laparo-
scopic radical prostatectomy and patient-specific 3D 
moulds were fabricated using MRI images. Of the 196 
patients, 3 patients with Gleason score 6, 127 patients 
with Gleason score 7, and 66 with Gleason score ≥ 8 dis-





Table 3 demonstrates the results of the Chi-square test 
of independence that examined the relation between 
those with low or intermediate risk disease or not and 
PI-RADS classification in patients with prostate cancer. 
The relation between these variables was statistically sig-
nificant, χ2 (2, N = 196) = 12.838, p = 0.002. There was a 
difference in the distribution of patients with PI-RADS 
3–5 between the low/intermediate risk GS group and the 
high-risk GS group. Approximately 80% of the patient in 
group 2 had a very high probability of csPCa (PI-RADS 
5). Over 13% of the patients from group 2 had an inter-
mediate probability of csPCa (PI-RADS 3).
Table 3 also shows the association between those with 
low/intermediate risk GS or not and tissue stiffness in 
kPa using USWE in patients with prostate cancer. The 
association between high risk GS or not and tissue stiff-
ness in Kpa using USWE was statistically significant, χ2 
(2, N = 196) = 23.577, p < 0.001. There was a difference 
in the distribution of measured stiffness between the 
low/intermediate GS group and the high risk GS group. 
About 90% of patients in the high risk GS group had a 
high stiffness (> 100  kPa) when using USWE. One third 
of the patients in the low/intermediate GS group was 
tested to have a low stiffness (< 100 kPa).
The association between PI-RADS and tissue stiff-
ness by USWE is presented in Table  4. Chi-square test 
and weighted kappa of independency and agreement 
Fig. 3 3D customised mould steps: (1) segmentation of MRI data in biomedical software MIMICS; (2) mold making in CAD software SolidWorks; (3) 
Ed printout from rapid prototyping machine Makerbot; (4) post‑radical prostatectomy specimen before dyeing and placing in the mold; (5) slicing 
of the prostate specimen with single blade; (6) the tissue slices arranged from the apex to the base; (7) the tissue slices are arranged from the apex 
to the base
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showed a weak relation between PI-RADS classification 
and tissue stiffness in patients with prostate cancer, χ2 (4, 
N = 196) = 11.084, p = 0.026. The correlation coefficient 
of the Chi-square, linear weighted kappa, and quadratic 
weighted kappa are 0.231, 0.034, and 0.078, respectively, 
which suggested association between PI-RADS by MRI 
and stiffness by USWE was weak.
Discussion
Risk stratification of prostate cancer based on imaging 
features remains a major focus of research and present 
study cohort in a non-screened population of men with 
prostate cancer provided an opportunity to test tran-
srectal USWE as an emerging imaging modality in com-
parison with mpMRI and histopathology of whole mount 
prostate gland. This is the largest series of cases reporting 
correlation of both mpMRI and USWE with the histo-
pathological GS. Multiparametric MRI and USWE were 
both very promising imaging modalities in characteris-
ing and differentiating low/intermediate risk cancer from 
high risk disease based on Gleason Score (GS). The study 
used radical prostatectomy histopathology as a reference 
standard for GS to avoid under-reporting of high risk dis-
ease on biopsy. Patient-specific mould-based orientation 
between histopathology and imaging ensured a better 
comparison than reported before. Statistically signifi-
cant correlations were observed between risks of Gleason 
score and PI-RADS classification on mpMRI. Similarly, a 
statistically significant high risk Gleason score on histo-
pathology was seen in patients with a high tissue stiffness 
on USWE imaging. However, a trend was seen where 
higher PI-RADS score was associated with stiffer prostate 
cancer lesions with a weak correlation. These findings 
have implications for USWE-guided biopsy of prostate 
cancer as an alternate to a more commonly practiced 
MRI-US fusion technique; however, further research is 
required including external validity.
Slaoui H et  al. in a retrospective analysis assessed 
correlation between PIRADS score and Gleason score 
of csPCa in 74 patients and showed no statistically sig-
nificant correlation between PIRADS score and Gleason 
score [28]. This is in contrast to our study, where the cor-
relation of the two groups was statistically significant. 
In an another study by Kızılay et  al. [29], a statistically 
significant correlation was reported between PIRADS 
score and Gleason score similar to findings of our study. 
The authors used whole-mount histopathology in a case 
series of 177 men as a reference standard; however, no 
patient-specific moulds were used in contrast to what we 
have carried out in the present study.
Table 3 Distribution of PI‑RADs classification using MRI and tissue stiffness using USWE in low/intermediate risk and high risk cancer 
prostate cancers based on Gleason score
*PI-RADS classification 3 means intermediate probability of clinically significant prostate cancer, 4 means high probability and 5 means very high probability of 
clinically significant prostate cancer; # Gleason score 3 + 3 and 3 + 4 were considered as low/intermediate risk cancer
Measurements Low/intermediate  risk# 
GS group (n = 97)
% High  risk^ GS 







 PI‑RADS 3 13 13.4 3 3.0
 PI‑RADS 4 28 28.9 17 17.2 12.838 2 0.002
 PI‑RADS 5 56 57.7 79 79.8
Stiffness (in Kpa) using USWE
 < 100 33 34.0 10 10.1
 100–130 12 12.4 35 35.4 23.577 2 < 0.001
 > 130 52 53.6 54 54.5
Table 4 Correlation between tissue stiffness (in kPa) using USWE and PI‑RADS classification using MRI in prostate cancer
* PI-RADS classification 3 means intermediate probability of clinically significant prostate cancer, 4 means high probability of clinically significant prostate cancer and 5 
means very high probability of clinically significant prostate cancer
PI-RADS 
classification*









weighted)< 100 (n = 43) % 100–130 
(n = 47)
% > 130 
(n = 106)
PI‑RADS 3 4 9.3 2 4.3 10 9.4 11.084 0.026 0.231 0.034 0.078
PI‑RADS 4 17 39.5 7 14.9 21 19.8
PI‑RADS 5 22 51.2 38 80.8 75 70.8
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Quantitative measurements of tissue stiffness using 
USWE have shown excellent characterisation and detec-
tion of csPCa [30–32]. This is based on a higher cellular 
density and microvascularisation with larger lesions pro-
ducing more stromal reactions and collagen deposition 
causing stiffer and more aggressive tissue [10, 33, 34]. In 
previous reports utilising USWE, Woo et  al. and Sunao 
et  al. reported a significant association between tissue 
stiffness measurements and Gleason score of csPCa [33, 
35], again similar to our findings.
USWE was able to provide additional information for 
detecting PCa and biopsy guidance and appeared to be 
comparable to other imaging modalities like MRI [12]. 
However, only a few studies reported a direct compres-
sion between MRI and USWE for PCa detection. One of 
these studies was done by Junker D et al. [36] who com-
pared MRI with real-time elastography and reported that 
both modalities have a high sensitivity in detecting high-
risk PCa. The small study of 39 men undergoing radical 
prostatectomy used real-time elastography which is sig-
nificantly different from USWE described in the present 
study. Most importantly, no pressure is required by the 
operator in USWE in contrast to real-time elastography. 
In our study, we found that using the stiffness values and 
PI-RADS score to predict the Gleason score of PCa was 
statistically significant. Combining mpMRI and USWE 
could decrease under the detection rate of csPCa.
The current study has limitations. Firstly, the inclusion 
criteria used in this study allowed only men with known 
localised prostate cancer opting for radical surgery and 
this introduces a selection bias. Secondly, the study is 
from a single institution with experienced operator per-
forming the test, most certainly USWE. Thirdly, the clini-
cal utility of pre-biopsy imaging needs further testing in 
men with raised PSA and abnormal digital examination. 
Further research is also needed to assess its external vali-
dation. We have recently reported role of USWE in pre-
dicting upgrading of GS from biopsy to radical surgery 
histopathology and further research should focus on the 
external validity of this study in men suspected to have 
prostate cancer.
A significant number of studies report improved pre-
cision of biopsy sampling of prostate cancer including 
image fusion of MR/US [37, 38]. Targeting of csPCa using 
clinical imaging has potential of reducing over-detection 
and over-treatment of prostate cancer, an issue associ-
ated with random systemic biopsies. Aigner et  al. [39] 
reported a significant improvement in prostate cancer 
detection rate per-core of biopsy tissue sample using real-
time elastographic detection of prostate cancer. Find-
ings from the present study should allow us to improve 
real-time targeting of csPCa using transrectal USWE 
and decrease number of biopsies with associated patient 
morbidity, in particular, when increasing numbers may 
not be yielding a higher detection rate. In a separate 
study [16], negative predictive value of transrectal USWE 
was 97% which certainly takes us closer to avoiding pros-
tate biopsy in men wherever indicated.
Conclusion
USWE and mpMRI are promising imaging modalities in 
detecting csPCa. The PI-RADS score of mpMRI and stiff-
ness value of USWE can predict risk-based Gleason score 
and can be used to facilitate image-guided sampling of 
csPCa.
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